Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioFlag is a leading biotechnology company specializing in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates a comprehensive platform for strain screening, clinical validation, and large-scale production, serving the dietary supplement, functional food, and pharmaceutical industries. BioFlag's portfolio includes clinically documented strains targeting gut health, immune modulation, allergy relief, and metabolic regulation. With advanced manufacturing facilities in China and Taiwan, the company provides end-to-end solutions from raw material supply to finished product formulation. BioFlag is recognized for its rigorous scientific approach, maintaining an extensive library of proprietary microbial strains with proven health benefits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioFlag Jinqi Biological.